DXCM(DexCom, Inc.) · 财务报表

DXCM(DexCom, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$2.45B$2.91B$3.62B$4.03B$4.66B
毛利润$1.68B$1.88B$2.29B$2.44B$2.80B
营业利润$265.80M$391.20M$597.70M$600.00M$911.80M
净利润$216.90M$341.20M$541.50M$576.20M$836.30M
经营现金流$442.50M$669.50M$748.50M$989.50M$1.44B
自由现金流$53.30M$304.70M$511.90M$630.70M$1.08B
摊薄每股收益$0.53$0.82$1.30$1.42$2.09

DexCom, Inc. DXCM